Effectiveness and safety of opicapone in Parkinson ’s disease patients with motor fluctuations: the OPTIPARK open-label study

ConclusionsOpicapone 50  mg was effective and generally well-tolerated in PD patients with motor fluctuations treated in clinical practice.Trial registrationRegistered in July 2016 at clinicaltrials.gov (NCT02847442).

Source: Translational Neurodegeneration - March 3, 2020 Category: Neurology Source Type: research